Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Oroshaza – page 18

221 clinical trials in Oroshaza, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Oroshaza at a glance
221
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

221 trials in Oroshaza

Open in trial search

Study of Pembrolizumab and Olaparib with Chemoradiation for Patients with Stage III Non-Small Cell Lung Cancer

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Merck Sharp & Dohme LLC

Colitis ulcerative

Not recruiting

Study on Long-Term Safety and Effectiveness of Upadacitinib for Patients with Ulcerative Colitis

Investigational
Countries:HungaryHungary
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Upadacitinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Chronic hepatitis B+1

Not recruiting

Study of Bepirovirsen for Patients with Chronic Hepatitis B on Nucleos(t)ide Analogue Treatment

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Bepirovirsen
  • Sponsor:Glaxosmithkline Research & Development Limited

Dyslipidaemia

Not recruiting

Study on the Effects of AZD0780 on Cholesterol Levels in Adults Aged 18-75 with Dyslipidemia

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Laroprovstat
  • Sponsor:Astrazeneca AB

Hypertension

Not recruiting

Study on the Effects of Telmisartan, Amlodipine, and Hydrochlorothiazide on Blood Pressure in Patients with Hypertension

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Amlodipine
  • Sponsor:KRKA tovarna zdravil d.d. Novo mesto

Study on Frexalimab for Treating Active Systemic Lupus Erythematosus in Patients

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Frexalimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study of Giredestrant Combined with Pertuzumab-Trastuzumab (Phesgo) for Patients with Previously Untreated HER2-Positive, Estrogen Receptor-Positive Locally Advanced or Metastatic Breast Cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:F. Hoffmann-La Roche AG

Study on Ertugliflozin for Children and Teens with Type 2 Diabetes

Investigational
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Ertugliflozin
  • Sponsor:Merck Sharp & Dohme LLC

Axial spondyloarthritis+1

Not recruiting

Study on Upadacitinib for Adults with Active Axial Spondyloarthritis

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Upadacitinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study on Vericiguat for Adults with Chronic Heart Failure with Reduced Ejection Fraction

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Vericiguat
  • Sponsor:Merck Sharp & Dohme LLC

Breast cancer

Not recruiting

Study Comparing ARV-471 and Fulvestrant for Patients with Advanced Estrogen Receptor-Positive, HER2-Negative Breast Cancer After Endocrine Treatment

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Fulvestrant
  • Sponsor:Pfizer Inc.

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen - Cilag International

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Oroshaza

What the registry says about research in the country

01 Cardiovascular Research

Innovative clinical trials focusing on heart failure prevention and treatment of atherosclerotic cardiovascular disease. Studies evaluate new therapeutic combinations and investigate treatments for patients with varying ejection fraction levels.

  • Heart Failure Management
  • Stroke Prevention
  • Atherosclerosis Treatment

Multiple trials are exploring novel drug combinations to improve outcomes in cardiac patients.

02 Dermatological Studies

Research initiatives examining treatments for moderate to severe plaque psoriasis and atopic dermatitis. Clinical trials are evaluating both adult and pediatric populations.

  • Psoriasis Management
  • Eczema Treatment
  • Long-term Safety Studies

Investigations include comparative studies of established and novel therapies for chronic skin conditions.

03 Metabolic Disorders

Comprehensive studies addressing Type 2 diabetes and obesity, with focus on weight management and metabolic health. Research includes evaluation of dyslipidemia treatments.

  • Weight Management
  • Diabetes Care
  • Lipid Management

Trials combine lifestyle interventions with innovative therapeutic approaches.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.